Stay updated on MGL-3196 in NASH Patients: Clinical Trial
Sign up to get notified when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.

Latest updates to the MGL-3196 in NASH Patients: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the page, and the prior government funding/status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a general funding/operating status notice referencing cc.nih.gov and opm.gov. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedDifference0.2%

- Check36 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. No user-facing changes to study content or page information were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedAdded related topics section for Non-alcoholic fatty liver disease and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedResults have been posted for the completed Phase 2 study of MGL-3196 (NCT02912260); the page now reflects updated objectives, outcomes, and supporting documentation, including the study status.SummaryDifference9%

Stay in the know with updates to MGL-3196 in NASH Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.